Marshall Wace North America L.P. - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2020$1,303,000
+976.9%
31,695
+1026.3%
0.01%
+700.0%
Q4 2019$121,000
-87.8%
2,814
-89.5%
0.00%
-83.3%
Q3 2019$995,000
-98.5%
26,908
-98.6%
0.01%
-97.5%
Q1 2019$67,184,000
+3785.7%
1,900,000
+4985.4%
0.24%
+1300.0%
Q4 2018$1,729,000
-4.4%
37,362
-2.1%
0.02%
+70.0%
Q4 2017$1,809,000
-49.6%
38,157
-42.6%
0.01%
-56.5%
Q3 2017$3,590,00066,4840.02%
Other shareholders
FIBROGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 195,707$168,8760.11%
ARMISTICE CAPITAL, LLC 7,892,000$6,810,0070.10%
Nan Fung Group Holdings Ltd 62,106$53,5910.04%
XTX Topco Ltd 174,496$150,5730.03%
BHK Investment Advisors, LLC 57,625$49,7250.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,557,128$2,206,5460.01%
FOX RUN MANAGEMENT, L.L.C. 42,720$36,8630.01%
PRIMECAP MANAGEMENT CO/CA/ 14,724,968$12,706,1750.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 38,634$4,0020.01%
Point72 Middle East FZE 342,385$295,4440.01%
View complete list of FIBROGEN INC shareholders